PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $360.52M in the quarter ending June 30, 2026, with 101.55% growth. This brings the company's total for the last twelve months to $1.01B, down -42.84% year-over-year. In the year 2025, PTC Therapeutics had annual revenue of $1.73B with 114.51% growth. That makes PTC Therapeutics the 7,584th largest company in the world by revenue and 1,781st in the United States.

• Revenue (ttm): $1.01B
• Revenue Growth: -42.84%
• P/S Ratio: 5.14
• Revenue / Employee: $1,017,915
• Employees: 991
• Market Cap: 5.18B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Translarna 321.07M 39.8%
• Emflaza 207.22M 25.7%
• Royalty 203.86M 25.3%
• All Other Products 36.95M 4.6%
• Translarna France 18.81M 2.3%
• Upstaza/Kebilidi 16.91M 2.1%
• Manufacturing 1.66M 0.2%
• Collaboration and License 304.00K 0.0%

By Geography

Chart

• United States (US) 413.04M 51.2%
• Non-US 393.74M 48.8%

Fiscal year ended Dec 31, 2024 See the full PTC Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.73B	923.88M	114.51%
Dec 31, 2024	806.78M	-131.04M	-13.97%
Dec 31, 2023	937.82M	239.02M	34.20%
Dec 31, 2022	698.80M	160.21M	29.75%
Dec 31, 2021	538.59M	157.83M	41.45%
Dec 31, 2020	380.77M	73.79M	24.04%
Dec 31, 2019	306.98M	42.25M	15.96%
Dec 31, 2018	264.73M	70.34M	36.19%
Dec 31, 2017	194.39M	111.69M	135.04%
Dec 31, 2016	82.71M	45.94M	124.95%
Dec 31, 2015	36.77M	11.52M	45.64%
Dec 31, 2014	25.25M	-9.45M	-27.24%
Dec 31, 2013	34.70M	750.00K	2.21%
Dec 31, 2012	33.95M	-71.47M	-67.80%
Dec 31, 2011	105.41M	100.45M	2,022.34%
Dec 31, 2005	4.97M	-	-

Data Source: Fiscal.ai Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error